Document is current
Any future updates will be listed below
-
Authors
Goodman, James https://orcid.org/0000-0002-1659-7644
Schain, Martin
Di Stefano, Giovanni
Lupson, Victoria
Horn, Tracy
Hill, Marion
Manavaki, Roie
Fryer, Timothy D.
Bumanlag-Amis, Elaine
Jalaludeen, Navazh
Jermutus, Lutz
Johansson, Edvin
Heurling, Kerstin
Haraldsson, Henrik
Evans, Mark
Cheriyan, Joseph
Johansson, Lars
Ambery, Philip
Wilkinson, Ian B.
-
Funding
Funding for this research was provided by:
University of Cambridge-AstraZeneca Experimental Medicines Training Initiative (RG98920, RG78426, RCAG/975 and RCZA/053, RG98920, RG78426, RCAG/975 and RCZA/053)
NIHR Cambridge Biomedical Research Centre (NIHR203312, NIHR203312)
- License Information
-
More Information
Article History
Received: 10 November 2024
Accepted: 27 May 2025
First Online: 1 July 2025
Declarations
:
: PA and LJ are employees and shareholders of AstraZeneca. All the remaining authors declare no conflict of interest.
